secwatch.observer — SEC 8-K summary
======================================

Issuer:     IGC Pharma, Inc. (IGC)
CIK:        0001326205
Form:       8-K
Filed at:   2026-01-06T23:59:59+00:00
Accession:  0001185185-26-000032
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IGC Pharma raises ~$234k in registered direct offering of 780k shares at $0.30/share
--------------------------------------------------------------------------------

- Issued 779,997 shares of common stock at $0.30 per share for gross proceeds of ~$234k.
- Offering closed on or about January 5, 2026 under existing shelf registration statement.
- Net proceeds to fund working capital, clinical development, R&D, and other business initiatives.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326205/000118518526000032/0001185185-26-000032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326205/000118518526000032/igc8k010526.htm
  HTML page:      https://secwatch.observer/filing/0001185185-26-000032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer